--- ## Safety, Side Effects & Monitoring ### Common Side Effects | Peptide | Common Effects | Management | |---------|---------------|------------| | CJC-1295 | Mild fatigue, water retention | Reduces over time | | Ipamorelin | Headache (rare), injection site reaction | Very well tolerated | | GHRP-6 | Intense hunger, water retention | Discuss with your provider | | IGF-1 LR3 | Hypoglycemia risk, joint pain | Requires monitoring | ### Safety Protocols 1
SURMOUNT-1 compared it with placebo in obesity so none of them is a comparison with cagrilintide
GI symptoms are the most common complaint on both drugs, and knowing normal vs call-now GI symptoms matters just as much as tracking aesthetic changes
and (3) identification of patient subgroups most likely to derive benefit or experience adverse outcomes from combination strategies
Which compound fits which goals After examining the clinical data, mechanisms, side effects, and availability, the question becomes practical
Peculiar glucagon processing in the intestine is the genesis of the paradoxical rise of serum pancreatic glucagon in patients after total pancreatectomy